IP Library Granted Patent US 8,119,382
Granted Patent B2
US 8,119,382 · App. 12/065,384 · Granted Feb 21, 2012

Variant of KpnI restriction endonuclease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,119,382
App. No.
12/065,384
Granted
Feb 21, 2012
Kind
B2
Abstract

Methods are provided for making restriction endonucleases with reduced star activity by one or more targeted mutations to a catalytic site within the restriction endonuclease. Examples of modifications to restriction endonucleases with significant sequence identity with KpnI are provided and reduced star activity demonstrated.

Claims (14)

1. A variant KpnI restriction endonuclease having at least 90% sequence identity with SEQ ID NO: 13 wherein

the amino acid at the position corresponding to amino acid 163 of SEQ ID NO: 13 is not Asp (D);

the amino acid at the position corresponding to amino acid 165 of SEQ ID NO: 13 is not Lys (K);

the amino acid at the position corresponding to amino acid 148 of SEQ ID NO: 13 is not a Asp (D);

the amino acid at the position corresponding to amino acid 175 of SEQ ID NO: 13 is not Gln (Q);

or

the amino acids at the positions corresponding to amino acids 163 and 165 of SEQ ID NO: 13 are not Asp (D) and Lys (K), respectively.

2. The variant KpnI restriction endonuclease according to claim 1 having an amino acid sequence consisting essentially of SEQ ID NO: 13, wherein

the amino acid at the position corresponding to amino acid 163 of SEQ ID NO: 13 is not Asp (D);

the amino acid at the position corresponding to amino acid 165 of SEQ ID NO: 13 is not Lys (K);

the amino acid at the position corresponding to amino acid 148 of SEQ ID NO: 13 is not a Asp (D);

the amino acid at the position corresponding to amino acid 175 of SEQ ID NO: 13 is not Gln (Q);

or

the amino acids at the positions corresponding to amino acids 163 and 165 of SEQ ID NO: 13 are not Asp (D) and Lys (K), respectively.

Assignments (3)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2023
From: NAGARAJA, VALAKUNJA; SARAVANAN, MATHESHWARAN
To: INDIAN INSTUTUTE OF SCIENCE
Reel/Frame 064623/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2023
From: ZHU, ZHENYU
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 064572/0351 →